TGF-β, to target or not to target; to prevent thyroid cancer progression?
- PMID: 35728736
- DOI: 10.1016/j.bbcan.2022.188752
TGF-β, to target or not to target; to prevent thyroid cancer progression?
Abstract
Thyroid cancer (TC) is a common endocrine cancer with a rising incidence. Current treatment fails to eliminate aggressive thyroid tumours, prompting an investigation into the processes that cause disease progression. In this review, we provide insight into TGF-β driven epithelial to mesenchymal transition (EMT), summarizing the current literature surrounding thyroid carcinogenesis, and discuss the potential for therapeutic strategies targeting the TGF-β signalling pathway. Understanding the underlying mechanisms that regulate cancer stem cell (CSC) growth and TGF-β signalling may provide novel therapeutic approaches for highly resistant TCs.
Keywords: Epithelial to mesenchymal transition; Thyroid cancer; Transforming growth factor beta.
Copyright © 2022 Elsevier B.V. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical